Virax Biolabs Group Limited.
VRAX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Virax Biolabs Group Limited is a biotechnology company focused on the detection, diagnosis, and prevention of viral diseases. The company develops and commercializes diagnostic test kits, including rapid antigen tests and PCR tests, for various viral infections. Virax Biolabs also offers services re...Show More
Better Health for All
0
No specific, concrete data points were found in the provided articles to score any of the KPIs against the quantitative thresholds in the rubric. The articles describe the company's focus on developing diagnostic tests and mention the enrollment of first patients in a clinical study in the United Kingdom in collaboration with the National Health Service.
1
However, they do not provide quantitative evidence regarding the percentage of the product portfolio delivering health benefits, revenue from harmful products, safety records, pricing accessibility, reach to vulnerable populations, risk transparency, R&D investment, health externalities, health equity programs, healthcare workforce support, preventative health measures, healthcare data responsibility, global health crisis response, mental health initiatives, pharma patent flexibility, nutrition and food safety, healthcare education, addiction mitigation, or specific details on clinical trial ethics beyond the fact that a study is underway.
Fair Money & Economic Opportunity
0
Virax Biolabs Group Limited is a biotechnology company focused on diagnostic test kits for viral diseases.
1
The provided article details company executives, compensation, and operations.
2
As a biotechnology company, its core business does not involve lending, insuring, moving, or storing money, nor does it offer consumer financial products or services. Therefore, all KPIs related to fair money and economic opportunity, which are designed for financial institutions, are not applicable to Virax Biolabs Group Limited and are scored as 0 according to the rubric's 'Not applicable' tiers.
Fair Pay & Worker Respect
0
No evidence available to assess Virax Biolabs Group Limited on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
The provided article details AmerisourceBergen's 2021 Supplier Code of Conduct, which is not relevant to VRAX.US.
1
Therefore, no specific, quantitative evidence regarding fair trade certifications, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, share of high-risk materials, or supplier diversity spend for VRAX.US was found.
2
Honest & Fair Business
0
No specific data points were found in the provided article to assess Virax Biolabs Group Limited against any of the 'Honest & Fair Business' KPIs.
1
The article focuses on product offerings and research in immune diagnostics, without mentioning regulatory fines, transparency benchmarks, whistle-blower policies, financial restatements, audit coverage, ESG controversies, complaint resolution times, board conflicts of interest, anti-corruption policies, or third-party verification of ethical claims.
2
Kind to Animals
0
The company undertakes pre-clinical studies on animals to examine the safety profile of its medications.
1
However, there is no specific data available regarding the percentage of products certified cruelty-free, the extent of non-animal testing methods employed, the number of animals used in testing annually, or any formal animal testing policy.
2
There is also no information on humane certifications for operations, wildlife conservation impact, ethical input substitution, supplier audits for welfare compliance, or sourcing from cage-free systems.
3
While the company engages with regulatory agencies like the FDA and MHRA, this engagement is for clinical study protocols and IVD classification, not explicitly for animal welfare policy improvement or advocacy for higher standards.
4
No War, No Weapons
0
No evidence was found in the provided articles to assess Virax Biolabs Group Limited against the 'No War, No Weapons' ethical value. The articles consistently focus on the company's biotechnology for vaccine efficacy testing and immune profiling, as well as strategic goals for clinical studies and global distribution, without mentioning any activities related to arms, defense, or conflict.
1
Planet-Friendly Business
0
No evidence available to assess Virax Biolabs Group Limited on Planet-Friendly Business.
Respect for Cultures & Communities
0
The provided article focuses on Virax Biolabs Group's establishment of a regional headquarters in Dubai Science Park and does not contain any specific, concrete data points relevant to the ethical value of Respect for Cultures & Communities or any of its associated KPIs.
1
Safe & Smart Tech
0
No evidence available to assess Virax Biolabs Group Limited on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, concrete data points related to waste management, product sustainability, or circular economy practices were found in the provided articles. The articles primarily focus on financial performance, operational expansion, and distribution agreements, without addressing any of the KPIs for Zero Waste & Sustainable Products.